Indaptus Therapeutics (NASDAQ:INDP – Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($0.38) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.41) by $0.03, Zacks reports.
Indaptus Therapeutics Stock Performance
Shares of NASDAQ INDP opened at $0.81 on Friday. The business’s 50 day moving average price is $0.86 and its 200-day moving average price is $1.08. Indaptus Therapeutics has a fifty-two week low of $0.70 and a fifty-two week high of $3.10. The company has a market cap of $11.37 million, a price-to-earnings ratio of -0.47 and a beta of 1.60.
About Indaptus Therapeutics
Featured Stories
- Five stocks we like better than Indaptus Therapeutics
- P/E Ratio Calculation: How to Assess Stocks
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- Differences Between Momentum Investing and Long Term Investing
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
- 3 Stocks to Consider Buying in October
- Why Costco Stock Is Poised to Hit $1,000 Again Soon
Receive News & Ratings for Indaptus Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indaptus Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.